Bracken
Ina Margaretha Rijnhout is an experienced leader in the biotechnology and life sciences sectors, currently serving as Chief Executive Officer at GlycoTreat, a company dedicated to developing glycan-based therapies for allergies. Since December 2022, Rijnhout has also been a Senior Partner at The Bracken Group, providing consultancy for life science product development, and a Business Development Executive at Freya Pharma Solutions, focused on women's sexual health. Additionally, Rijnhout has been a Managing Partner at KENKO INTERNATIONAL BV since September 2008, supporting life science SMEs in various strategic initiatives. Past roles include Chief Executive Officer at DC4U, which developed immunotherapy solutions, and Chief Business Officer at Lamina Therapeutics, working on innovative medical devices. Rijnhout has held strategic positions at PharmaNet and Kendle International throughout a distinguished career that began after earning an MSc in Medical Sciences from Leiden University.
This person is not in any offices
Bracken
Bracken offers consulting, regulatory, analytics, marketing, and sales enablement solutions for life sciences and digital health companies. We enable businesses to work with broader capabilities, deeper expertise, better processes, more data, and a greater network